These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27979613)

  • 21. Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA.
    Álvarez VJ; Bravo SB; Chantada-Vazquez MP; Colón C; De Castro MJ; Morales M; Vitoria I; Tomatsu S; Otero-Espinar FJ; Couce ML
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pictorial review of the radiographic skeletal findings in Morquio syndrome (mucopolysaccharidosis type IV).
    Padash S; Obaid H; Henderson RDE; Padash Y; Adams SJ; Miller SF; Babyn P
    Pediatr Radiol; 2023 May; 53(5):971-983. PubMed ID: 36627376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.
    Morrone A; Tylee KL; Al-Sayed M; Brusius-Facchin AC; Caciotti A; Church HJ; Coll MJ; Davidson K; Fietz MJ; Gort L; Hegde M; Kubaski F; Lacerda L; Laranjeira F; Leistner-Segal S; Mooney S; Pajares S; Pollard L; Ribeiro I; Wang RY; Miller N
    Mol Genet Metab; 2014 Jun; 112(2):160-70. PubMed ID: 24726177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.
    Tomatsu S; Mackenzie WG; Theroux MC; Mason RW; Thacker MM; Shaffer TH; Montaño AM; Rowan D; Sly W; Alméciga-Díaz CJ; Barrera LA; Chinen Y; Yasuda E; Ruhnke K; Suzuki Y; Orii T
    Res Rep Endocr Disord; 2012 Dec; 2012(2):65-77. PubMed ID: 24839594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.
    Tomatsu S; Okamura K; Taketani T; Orii KO; Nishioka T; Gutierrez MA; Velez-Castrillon S; Fachel AA; Grubb JH; Cooper A; Thornley M; Wraith E; Barrera LA; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Kondo N; Creer M; Noguchi A
    Pediatr Res; 2004 Apr; 55(4):592-7. PubMed ID: 14711889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA.
    Lin HY; Chuang CK; Chen MR; Chiu PC; Ke YY; Niu DM; Tsai FJ; Hwu WL; Lin JL; Lin SP
    Orphanet J Rare Dis; 2014 Feb; 9():21. PubMed ID: 24513086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA.
    Leal AF; Alméciga-Díaz CJ
    Gene Ther; 2023 Feb; 30(1-2):107-114. PubMed ID: 35581402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morquio disease (Mucopolysaccharidosis type IV-A): clinical aspects, diagnosis and new treatment with enzyme replacement therapy].
    Politei J; Schenone AB; Guelbert N; Fainboim A; Szlago M
    Arch Argent Pediatr; 2015 Aug; 113(4):359-64. PubMed ID: 26172013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
    Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
    Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene.
    Terzioglu M; Tokatli A; Coskun T; Emre S
    Hum Mutat; 2002 Dec; 20(6):477-8. PubMed ID: 12442278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?
    Tomatsu S; Montaño AM; Oikawa H; Dung VC; Hashimoto A; Oguma T; Gutiérrez ML; Takahashi T; Shimada T; Orii T; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):195-202. PubMed ID: 24953405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
    Lyseng-Williamson KA
    BioDrugs; 2014 Oct; 28(5):465-75. PubMed ID: 25200032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy.
    Bertolin J; Sánchez V; Ribera A; Jaén ML; Garcia M; Pujol A; Sánchez X; Muñoz S; Marcó S; Pérez J; Elias G; León X; Roca C; Jimenez V; Otaegui P; Mulero F; Navarro M; Ruberte J; Bosch F
    Nat Commun; 2021 Sep; 12(1):5343. PubMed ID: 34504088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth impairment in mucopolysaccharidoses.
    Melbouci M; Mason RW; Suzuki Y; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2018 May; 124(1):1-10. PubMed ID: 29627275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.